Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab
Todd J. Schwedt, Simona Nikolova, Gina Dumkrieger, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Connectivity Analysis in EEG Data: A Tutorial Review of the State of the Art and Emerging Trends
Giovanni Chiarion, Laura Sparacino, Yuri Antonacci, et al.
Bioengineering (2023) Vol. 10, Iss. 3, pp. 372-372
Open Access | Times Cited: 70
Artificial Intelligence for Automatic Pain Assessment: Research Methods and Perspectives
Marco Cascella, Daniela Schiavo, Arturo Cuomo, et al.
Pain Research and Management (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 50
The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics
William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study
Hauke Basedau, Kuan‐Po Peng, Marlene Schellong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients
Edina Szabó, Nicolas R. Bolo, David Borsook, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access
Imaging of Migraine and Vestibular Migraine
Roberta Messina, Maria A. Rocca, Massimo Filippi
(2025), pp. 185-202
Closed Access
Effects of acute sleep deprivation on the brain function of individuals with migraine: a resting-state functional magnetic resonance imaging study
Shuqing Wang, Lin Ma, Song Wang, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Periaqueductal gray functional connectivity abnormalities associated with acute post-traumatic headache
Simona Nikolova, Catherine D. Chong, Jing Li, et al.
Journal of Neurology (2025) Vol. 272, Iss. 5
Closed Access
Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response
Gabriella Juhász, Kinga Gecse, Dániel Baksa
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108523-108523
Open Access | Times Cited: 10
Imaging the brain and vascular reactions to headache treatments: a systematic review
Roberta Messina, René Christensen, I. Cetta, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
Carmen Sánchez-Rodríguez, Ana Beatriz Gago‐Veiga, David García‐Azorín, et al.
Current Pain and Headache Reports (2023)
Closed Access | Times Cited: 7
Multilayer network changes in patients with migraine
Jinseung Kim, Dong Ah Lee, Ho‐Joon Lee, et al.
Brain and Behavior (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 7
Parahippocampus hypertrophy drives gray matter morphological alterations in migraine patients without aura
Tao Yin, Lei Lan, Zilei Tian, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Journal of Neurology (2023) Vol. 270, Iss. 11, pp. 5600-5612
Open Access | Times Cited: 5
Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients
Marianna La Rocca, Anna Laporta, Livio Clemente, et al.
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 4
Disrupted topologic efficiency of white matter structural connectome in migraine: a graph-based connectomics study
Yanliang Mei, Dong Qiu, Zhonghua Xiong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old
Masahito Katsuki, Kenta Kashiwagi, Shin Kawamura, et al.
Cureus (2023)
Open Access | Times Cited: 3
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab
Haidar Muhsen Al-Khazali, Håkan Ashina, Rune Häckert Christensen, et al.
Cephalalgia (2024) Vol. 44, Iss. 6
Open Access
Page 1

Scroll to top